biostudies-literatureKilleen OJNEI NIH HHSNCCDPHP CDC HHS23-28https://www.ebi.ac.uk/biostudies/studies/S-EPMC10246914biostudies-literatureUnknown6(1)<h4>Purpose</h4>To assess the efficacy of the Support, Educate, Empower (SEE) glaucoma coaching program on medication adherence among poorly adherent patients with glaucoma for 12 months after cessation of the intervention.<h4>Design</h4>Uncontrolled intervention study with a pre-post design.<h4>Participants</h4>The SEE cohort was recruited from the University of Michigan and included patients with glaucoma aged ≥ 40 years, taking ≥ 1 medication, who self-reported poor adherence. Electronic medication monitoring of those who completed the program continued for up to 1 year after the coaching intervention.<h4>Methods</h4>Adherence was monitored electronically (AdhereTech) during the 7-month program and 12-month follow-up period. Adherence was the percentage of doses taken on time. ParticipaOphthalmology. GlaucomaGlaucoma Medication Adherence 1 Year after the Support, Educate, Empower Personalized Glaucoma Coaching Program.PMC10246914U01 DP006442R01 EY031337K23 EY025320R21 EY020912R21 EY028997Niziol LMCho JResnicow KDarnley-Fisch DNewman-Casey PALee PPKilleen OJHeisler MMusch DCfalseGlaucoma Medication Adherence 1 Year after the Support, Educate, Empower Personalized Glaucoma Coaching Program.<h4>Purpose</h4>To assess the efficacy of the Support, Educate, Empower (SEE) glaucoma coaching program on medication adherence among poorly adherent patients with glaucoma for 12 months after cessation of the intervention.<h4>Design</h4>Uncontrolled intervention study with a pre-post design.<h4>Participants</h4>The SEE cohort was recruited from the University of Michigan and included patients with glaucoma aged ≥ 40 years, taking ≥ 1 medication, who self-reported poor adherence. Electronic medication monitoring of those who completed the program continued for up to 1 year after the coaching intervention.<h4>Methods</h4>Adherence was monitored electronically (AdhereTech) during the 7-month program and 12-month follow-up period. Adherence was the percentage of doses taken on time. Participa2023-01-01T00:00:00Z2023 Jan-Feb2025-04-26T06:57:42.661Z2025-04-06T12:03:02.143ZS-EPMC102469143595302110.1016/j.ogla.2022.08.001